MedPath

Ceftobiprole medocaril

Generic Name
Ceftobiprole medocaril
Brand Names
Zevtera
Drug Type
Small Molecule
Chemical Formula
C26H26N8O11S2
CAS Number
376653-43-9
Unique Ingredient Identifier
YXV28V1B07

Overview

Ceftobiprole medocaril is a ceftobiprole prodrug.

Indication

No indication information available.

Associated Conditions

  • Pneumonia

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2023/05/12
Phase 3
Completed
2019/11/20
N/A
Completed
Advanz Pharma
2018/02/20
Phase 3
Completed
2017/10/23
Phase 2
Completed
2017/05/03
Phase 3
Completed
2017/05/02
Phase 3
Completed
2015/08/19
Phase 1
Terminated
2007/09/14
Phase 3
Terminated
2007/07/23
Phase 2
Withdrawn
2006/05/16
Phase 3
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.